Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su-Jiang Zhang

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2011
[c-CBL gene and myeloid malignancy]Chao Sun, Su-Jiang Zhang
Current Hematologic Malignancy Reports|December 16, 2011
Disordered epigenetic regulation in the pathophysiology of myeloproliferative neoplasmsSu-Jiang Zhang, Omar Abdel-Wahab
Chinese Medical Journal|December 17, 2008
An update of molecular pathogenesis and diagnosis of myeloproliferative disorders in the JAK2 eraSu-jiang Zhang, Jian-yong Li
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2013
[IDH gene mutations and acute myeloid leukemia]Chao Sun, Su-jiang Zhang, Jian-yong Li
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 6, 2013
[RNA spliceosomal mutations in myeloid neoplasms]Xiang-chou Yang, Su-jiang Zhang, Hong-xia Qiu
Oncotarget|February 18, 2017
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemiaYuan Ouyang, Chun Qiao, Yu Chen, et al.
Leukemia Research|March 24, 2009
GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphismSu-Jiang Zhang, Jing-Yi Shi, Jian-Yong Li
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 7, 2011
[Progression of sorafenib in the treatment of acute myeloid leukemia]Xiao-juang Zhou, Su-jiang Zhang, Yun-feng Shen
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[Molecular markers related to prognosis of acute myeloid leukemia-review]Chao Sun, Su-Jiang Zhang, Jian-Yong Li, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Mutation of tet2 gene and malignant blood disease]Xi-Feng Qian, Yun-Feng Shen, Su-Jiang Zhang, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2011
[c-CBL gene and myeloid malignancy]Chao Sun, Su-Jiang Zhang
Current Hematologic Malignancy Reports|December 16, 2011
Disordered epigenetic regulation in the pathophysiology of myeloproliferative neoplasmsSu-Jiang Zhang, Omar Abdel-Wahab
Chinese Medical Journal|December 17, 2008
An update of molecular pathogenesis and diagnosis of myeloproliferative disorders in the JAK2 eraSu-jiang Zhang, Jian-yong Li
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2013
[IDH gene mutations and acute myeloid leukemia]Chao Sun, Su-jiang Zhang, Jian-yong Li
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 6, 2013
[RNA spliceosomal mutations in myeloid neoplasms]Xiang-chou Yang, Su-jiang Zhang, Hong-xia Qiu
Oncotarget|February 18, 2017
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemiaYuan Ouyang, Chun Qiao, Yu Chen, et al.
Leukemia Research|March 24, 2009
GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphismSu-Jiang Zhang, Jing-Yi Shi, Jian-Yong Li
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 7, 2011
[Progression of sorafenib in the treatment of acute myeloid leukemia]Xiao-juang Zhou, Su-jiang Zhang, Yun-feng Shen
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2009
[Molecular markers related to prognosis of acute myeloid leukemia-review]Chao Sun, Su-Jiang Zhang, Jian-Yong Li, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Mutation of tet2 gene and malignant blood disease]Xi-Feng Qian, Yun-Feng Shen, Su-Jiang Zhang, et al.
Pageof 8